Biocon signs MoU with Malaysia's Biotechcorp

Biocon is in talks with BiotechCorp to manufacture Biopharmaceutical products and formulation, within Malaysia's Nusajaya, Iskandar Malaysia, called the Bio-XCell Ecosystem. Biocon is also developing biotechnology infrastructure in the Bio-XCell Ecosystem Project.

Kiran Mazumdar-Shaw Chairman and Managing Director, Biocon said, "Biocon is keen to explore Malaysia as a destination for our expansion. Malaysia and the Bio-XCell Ecosystem in Iskandar Malaysia are attractive propositions. We are interested in learning how we can leverage this offering with our commercial plans and look forward to formalizing our engagement with BiotechCorp further".

"Biocon is India's first biotech company and Asia's largest publicly-listed biopharma company with a current market cap of a little over USD 1.2 billion. It is encouraging that they are taking a positive view of Malaysia as a rapidly developing biotech hub. Additionally, with the development of the Bio-XCell Ecosystem we are now able to offer a comprehensive support infrastructure, as well as the required supply of knowledge workers, favorable environment, and provision of related services," said Dato' Iskandar Mizal Mahmood, Chief Executive Officer, BiotechCorp.

The collaboration while giving Biocon a conducive ecosystem to further its biopharmaceutical activities; will also enable the transfer of knowledge to Malaysia's human capital, create employment and knowledge workers, and directly benefit the growth of similar local industry.

DH Newsletter Privacy Policy Get top news in your inbox daily
Comments (+)